Novel composition for treating metabolic syndrome

Details Novel composition for treating metabolic syndrome Novel composition for treating metabolic syndrome

A - Human Necessities

61

K

A61K 31/616 (2006.01) A61K 31/137 (2006.01) A61K 31/155 (2006.01) A61K 31/167 (2006.01) A61K 31/18 (2006.01) A61K 31/192 (2006.01) A61K 31/196 (2006.01) A61K 31/198 (2006.01) A61K 31/4045 (2006.01) A61K 31/405 (2006.01) A61K 31/609 (2006.01) A61K 45/06 (2006.01) A61P 3/00 (2006.01) A61P 3/04 (2006.01)

Patent

CA 2675638

The invention relates to a composition that includes a first agent selected from the group consisting of an oxidative phosphorylation inhibitor, an ionophore, and an adenosine 5'-monophosphate-activated Protein kinase (AMPK) activator; a second agent that possesses anti-inflammatory activity; and a third agent that possesses serotonin activity.

L'invention concerne une composition comprenant un premier agent choisi dans le groupe constitué par un inhibiteur de la phosphorylation oxydative, un ionophore et un activateur de la protéine kinase activée par l'adénosine 5'-monophosphate (AMPK), un deuxième agent présentant une activité anti-inflammatoire et un troisième agent présentant une activité sérotonine.

Affiliated with

Also associated with

Rating

Novel composition for treating metabolic syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel composition for treating metabolic syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel composition for treating metabolic syndrome will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1424395